6,942 Shares in Genpact Limited (NYSE:G) Purchased by KBC Group NV

KBC Group NV purchased a new stake in Genpact Limited (NYSE:G) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 6,942 shares of the business services provider’s stock, valued at approximately $298,000.

Several other large investors have also recently added to or reduced their stakes in G. Blue Trust Inc. raised its holdings in shares of Genpact by 8.7% in the fourth quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider’s stock valued at $217,000 after buying an additional 441 shares during the last quarter. SG Americas Securities LLC acquired a new stake in Genpact in the 4th quarter valued at about $238,000. Phillips Wealth Planners LLC acquired a new stake in Genpact in the 4th quarter valued at about $201,000. Crossmark Global Holdings Inc. raised its position in shares of Genpact by 1.6% during the fourth quarter. Crossmark Global Holdings Inc. now owns 396,264 shares of the business services provider’s stock worth $17,020,000 after acquiring an additional 6,275 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB raised its stake in shares of Genpact by 22.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 3,378 shares of the business services provider’s stock worth $145,000 after buying an additional 619 shares during the last quarter. 96.03% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently issued reports on G shares. TD Cowen boosted their price objective on shares of Genpact from $40.00 to $45.00 and gave the company a “hold” rating in a report on Friday, November 8th. Robert W. Baird upped their target price on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and boosted their target price for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Finally, Needham & Company LLC boosted their price target on shares of Genpact from $42.00 to $55.00 and gave the stock a “buy” rating in a research report on Monday, November 11th. Six research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $44.50.

Insider Buying and Selling at Genpact

In other news, CEO Balkrishan Kalra sold 13,600 shares of the business’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $44.60, for a total value of $606,560.00. Following the completion of the sale, the chief executive officer now owns 267,404 shares of the company’s stock, valued at approximately $11,926,218.40. The trade was a 4.84 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Piyush Mehta sold 12,000 shares of the firm’s stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the transaction, the senior vice president now directly owns 151,182 shares in the company, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 35,058 shares of company stock valued at $1,558,675 in the last quarter. 2.80% of the stock is currently owned by insiders.

Genpact Stock Up 0.5 %

Genpact stock opened at $48.94 on Tuesday. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85. The company’s 50-day moving average is $44.75 and its 200-day moving average is $40.92. The firm has a market capitalization of $8.63 billion, a PE ratio of 13.44, a P/E/G ratio of 1.61 and a beta of 1.20. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $49.15.

Genpact (NYSE:G) last released its quarterly earnings data on Thursday, November 7th. The business services provider reported $0.75 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.04. Genpact had a return on equity of 21.85% and a net margin of 14.22%. The firm had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.19 billion. During the same quarter in the prior year, the company earned $0.67 earnings per share. Sell-side analysts anticipate that Genpact Limited will post 2.94 earnings per share for the current year.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.